
A zzso zzso phase II study was conducted in zzso patients, most with zzso zzso to evaluate whether zzso would reduce new zzso on zzso 

zzso necrosis factor zzso has been implicated in zzso zzso has been identified in active zzso zzso is toxic to zzso in zzso and worsens the severity of experimental allergic zzso zzso in zzso zzso a zzso zzso zzso zzso zzso fusion protein zzso zzso protects against zzso 

Patients received 10, 50, or 100 zzso of zzso or zzso IV every 4 weeks for up to 48 zzso zzso scans and clinical evaluations were performed at zzso at zzso and then every 4 weeks zzso before zzso through study week zzso 

There were no significant differences between groups on any zzso study measure, but the number of zzso patients experiencing zzso was significantly increased compared with patients receiving zzso zzso zzso zzso and their zzso occurred earlier zzso zzso zzso zzso deficits tended to be more severe in the zzso treatment groups, although this did not affect Expanded zzso zzso zzso zzso zzso zzso were present in a substantial number of treated zzso serum zzso trough zzso were zzso in only a zzso zzso events that increased in frequency in treated patients included headache, zzso abdominal pain, and hot zzso 

zzso failed to be zzso but insight into the role of zzso in zzso zzso was zzso 

